The messenger sector is presently experiencing substantial growth, fueled by the successful deployment of mRNA-based medications against COVID-19. Research reveal a complex landscape, with ongoing capital into therapeutic applications separate from infectious diseases, including areas such as oncology, rare diseases, and protein replacement trea… Read More